Innovation Pharmaceuticals Total Debt vs. Return On Equity
| IPIX Stock | USD 0.0001 0.00 0.00% |
For Innovation Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Innovation Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Innovation Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Innovation Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Innovation Pharmaceuticals over time as well as its relative position and ranking within its peers.
Innovation |
Innovation Pharmaceuticals Return On Equity vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Innovation Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Innovation Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Innovation Pharmaceuticals is rated fourth overall in total debt category among its peers. It is currently regarded as number one stock in return on equity category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Innovation Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Innovation Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Innovation Total Debt vs. Competition
Innovation Pharmaceuticals is rated fourth overall in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 45.48 Million. Innovation Pharmaceuticals holds roughly 1.24 Million in total debt claiming about 2.73% of equities under Health Care industry.
Innovation Return On Equity vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Innovation Pharmaceuticals |
| = | 1.24 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Innovation Pharmaceuticals |
| = | -1.09 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Innovation Return On Equity Comparison
Innovation Pharmaceuticals is currently under evaluation in return on equity category among its peers.
Innovation Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Innovation Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Innovation Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Innovation Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Innovation Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts. Innovation Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Innovation Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Innovation Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Innovation Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Innovation Pharmaceuticals' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Innovation Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Use Investing Themes to Complement your Innovation Pharmaceuticals position
In addition to having Innovation Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corporate Bonds Funds Thematic Idea Now
Corporate Bonds Funds
Funds or Etfs investing in different types of corporate debt instruments. The Corporate Bonds Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Innovation Pink Sheet Analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.